Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    MEFV Antibody, DyLight 755, Novus Biologicals™
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP280113IR
                        
                            
                        
                        
                        
                            
                        
                        
                        
                        
                            
                                    
                                This item is not returnable.
                                View return policy
                                
                        
                    
                Description
MEFV Polyclonal antibody specifically detects MEFV in Human samples. It is validated for Western BlotSpecifications
| MEFV | |
| Polyclonal | |
| 50mM Sodium Borate | |
| Rabbit | |
| Epitope affinity purified | |
| RUO | |
| Primary | |
| Human | |
| Purified | 
| Western Blot | |
| DyLight 755 | |
| FMF, FMFmarenostrin, Marenostrin, Mediterranean fever, MEFpyrin, MGC126560, MGC126586, TRIM20 | |
| Synthetic peptide corresponding to aa 2-29 (A2KTPSDHLLSTLEELVPYDFEKFKFKLQ29) of human MEFV. | |
| 0.1 mL | |
| Cell Biology, Cytoskeleton Markers, Immunology, Innate Immunity, Signal Transduction | |
| 4210 | |
| Store at 4°C in the dark. | |
| IgG | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction